See section j, attachment 1, statement of work (SOW) titled, defining laboratory derangements from non-compressible hemorrhage: a pilot study to aid in developing blood transfusion solutions, and…
Ended Definitive Contract Awarded Last action
- Contract number
- FA238425CB046
- Awardee
-
University Of Maryland, Baltimore UEI Z9CRZKD42ZT1
- Awarding agency
-
Air Force
Department of Defense
- Obligated
- $740,126
Award facts
- Opportunity
-
- CHEERS MAA Open Period 3 - All Technical Areas, 10 U. S. C 3458 - Commercial Solutions Opening (CSO) Solicitation · FA238424S2336 · Posted Jul 29, 2024
- Contract value 100% obligated
- $740,126.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- Contracting staff
- Funding agency
- Air Force Materiel Command Air Force, Department of Defense
- NAICS code
- 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
- Set-aside
- No set-aside
- Competition
- Competed under SAP · 1 offer Simplified Acquisition
- Pricing
- Firm Fixed Price
- Place of performance
- Baltimore, MD 21201, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Other Administrative Action | $0 | |
| Original award | $740,126 |
About this award
The University of Maryland, Baltimore has been awarded a $740,126 firm fixed-price contract by the Air Force Research Laboratory to conduct research titled "Defining Laboratory Derangements from Non-Compressible Hemorrhage: A Pilot Study to Aid in Developing Blood Transfusion Solutions." The contract, awarded on September 30, 2025, with completion targeted for September 30, 2026, supports the Air Force's medical research initiatives focused on trauma care and operational medicine. Work will be performed at the institution's Baltimore Campus location. This award carries no set-aside designation and represents a direct competitive award under the Air Force Research Laboratory's Human Effectiveness Directorate programs, which focus on advancing military medical capabilities and addressing critical capability gaps in combat casualty care.
The research directly supports the Air Force's mission to enhance medical readiness and survival outcomes for military personnel by investigating laboratory biomarkers and physiological responses associated with non-compressible hemorrhage—a leading cause of preventable combat deaths. Findings from this pilot study will inform the development of optimized blood transfusion protocols and resuscitation strategies for trauma situations. The University of Maryland, Baltimore brings substantial research infrastructure and expertise in biomedical sciences to this effort, with demonstrated experience managing complex Air Force-funded research programs and maintaining established relationships with the Air Force Research Laboratory across multiple medical research domains.
Description
See section j, attachment 1, statement of work (SOW) titled, defining laboratory derangements from non-compressible hemorrhage: a pilot study to aid in developing blood transfusion solutions, and attachment 2, SOW supplemental requirements (afrl/PZL)
Quick answers
Who was awarded contract FA238425CB046?
FA238425CB046 was awarded to University Of Maryland, Baltimore by Air Force (Department of Defense) on September 30, 2025.
How much is contract FA238425CB046 worth?
The government has obligated $740,126 on FA238425CB046.
Which agency awarded contract FA238425CB046?
Air Force (Department of Defense) awarded FA238425CB046, with funding from Air Force Materiel Command (Air Force).
Was contract FA238425CB046 competed?
The extent of competition for FA238425CB046 was competed under sap. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award